You are now leaving the Kedrion Corporate site. The information available in your chosen website may not be in compliance with EU legislation regulating the advertising of medicinal products for human use, nor do the opinions expressed necessarily reflect the Company’s positions or are endorsed by it. In addition as per local health authority Regulations, some of our products are not approved for sales, marketing or distribution in all countries.
NEWS / EVENTS / .........

EVENTS - 08-08-2018

Kedrion Joins Annual PNS Conference on Neurology

Almost 700 experts representing 44 countries joined the 2018 Peripheral Nerve Society (PNS) Conference in Baltimore, MD (USA) from 21 to 25 July. A total of 386 abstracts, and plenty of high-profile scientific contents, were presented during this Conference.

Kedrion Biopharma attended with a booth dedicated to the Immunoglobulin-based product marketed in US. Moreover, Kedrion supported a delegation of 40 international guests coming from Italy, Poland, Serbia, Turkey, Portugal, Colombia and the United Arab Emirates.

Among the 386 abstracts, Kedrion presented a poster discussing the types of clinical trials that might be more suitable for the different Immunoglobulin indications.

Kedrion looks forward to participating in the next PNS Conference, which will be held in Genoa, Italy, from 22 to 26 June 2019.

For more information please contact: